Le Lézard
Classified in: Health

Food Recall Warning (Allergen) - Great Value brand Chicken Burgers recalled due to undeclared egg


Product photo is available: https://recalls-rappels.canada.ca/en/alert-recall/great-value-brand-chicken-burgers-recalled-due-undeclared-egg

OTTAWA, ON, Dec. 3, 2021 /CNW/ -

Summary

Affected products

Brand

Product

Size

UPC

Codes

Great Value

Chicken Burgers

904 g (8 x 113 g)

6 28915 82529 9

Best Before:

2022 MA 01

2022 MA 27

2022 JL 06

2022 JL 12

2022 JL 17

Issue

Belmont Meat Products Ltd. is recalling Great Value brand Chicken Burgers from the marketplace because they may contain egg which is not declared on the label.

The recalled product has been sold nationally.

What you should do

Learn more:

Background

This recall was triggered by Canadian Food Inspection Agency test results.

There have been no reported reactions associated with the consumption of this product.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated food recall warnings.

The CFIA is verifying that industry is removing the recalled product from the marketplace.

Également disponible en français

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: